|
Listing #410767 – For Sale ALARA Metri Scan Bone Densitometer
|
|
This Premium Listing has been seen 17 times and clicked on 341 times (as of 05:00 pm edt)
 |
|
Updated: August 25, 2008
|
|
Asking Price: $9,998.00 USD
Condition: Excellent
|
Manufacture: Alara
Model: Metri Scan Bone Mineral Density
Price: $9,998.00
Accessories:
* Alara Metri Scan
* Manual
* Power cord
* Weight 42 lbs
* Dimensions 16" x 16" x 16"
* Precision Error 1.1% CV (in vivo)
* Patient x-ray dose 0.001 mrem (effective dose equivalent)
* Mains voltage 100 - 240 vac
* Mains frequency 50 - 60 Hz
Description:
On Site Financing Available!!
Metri Scan lets the primary care physician screen patients\' bone mineral density (BMD) during a routine office exam. This type of test typically requires a visit to the hospital imaging center for a Central DEXA examination.
Physicians now have a front line diagnostic tool that will help them identify patients who may have low BMD and be at risk for osteoporotic fractures. Using a one minute procedure that scans the patient\'s hand, physicians can assess osteoporosis risk. This is critically important today, as osteoporosis was recently determined to be significantly underdiagnosed.
The Metri Scan System Concept
MetriScan lets the primary care physician screen patients\' bone mineral density (BMD) during a routine office exam. This type of test typically requires a visit to the hospital imaging center for a Central DEXA examination.
Physicians now have a front line diagnostic tool that will help them identify patients who may have low BMD and be at risk for osteoporotic fractures. Using a one minute procedure that scans the patient\'s hand, physicians can assess osteoporosis risk. This is critically important today, as osteoporosis was recently determined to be significantly underdiagnosed.
Indications for MetriScan Use
Indications for Use
MetriScan is indicated for use in estimating relative bone mineral density (BMD). The estimate of relative BMD and T-score may be used as an aid to the physician in assessing fracture risk, and for monitoring changes in bone mass over time.
Who should have Bone Mineral Density (BMD) testing?
* Perimenopausal women with risk factors for osteoporosis, including cigarette smoking or corticosteroid use.
* Postmenopausal women who are undecided regarding hormonal replacement therapy or use of other drugs to prevent/treat osteoporosis.
* Postmenopausal women under age 65 who have one or more additional risk factors for osteoporotic fracture (besides menopause).
* All women aged 65 and older regardless of additional risk factors.
* Postmenopausal women who present with fractures or evidence of reduced BMD on plain x-ray (to confirm diagnosis and determine disease severity).
* Women being monitored during treatment of osteoporosis.
* Men and women under treatment for conditions where the medication may affect BMD.
|
|
DOTmed's COMPLIANCE NOTICE AND COMPLIANCE COMPLAINT PROCEDURE.
|
